Delivery Order SPE2DB22D3004-SPE2DB25FPP25

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,440.51 firm-fixed-price delivery order is for the supply of 4566802887 LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, identified as SPE2DB22D1202|SPE2DB25FUQA0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,448.19, is a Delivery Order for the supply of 4566975699 - LISDEXAMFETAMINE 30 MG CAPSULE 100S. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.70, is for the delivery of 4566995949 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order, with a period of performance through January 22, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,047.19, is for the delivery of 4566962997 LISDEXAMFETAMINE 10 MG CAPSULE 100S. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,301.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567394902 - LISDEXAMFETAMINE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract....
This federal contract award, valued at $2,328.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567038547 - LISDEXAMFETAMINE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, with ID SPE2DB20D1004|SPE2DB25FNEFR, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566961884 - LISDEXAMFETAMINE 30 MG CAPSULE 100S, with a ceiling value of $1,111.48 and a completion date of January 17, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,180.65 delivery order contract is for the supply of 4567113101 - LISDEXAMFETAMINE 20 MG CAPSULE 100S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,631.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566895459 - LISDEXAMFETAMINE 20 MG CAPSULES 100S. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
The federal contract award, identified as SPE2DX15D1053|SPE2DX25F6FRS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,305.96 firm-fixed-price delivery order is for the supply of 4566822742 LISDEXAMFETAMINE 10 MG CAPSULE 100S. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPP25
    Delivery Order

This federal contract award, with the ID SPE2DB22D3004|SPE2DB25FPP25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,899.51, is for the delivery of LISDEXAMFETAMINE 60 MG CAPSULE 100S, a pharmaceutical product, with a completion date of February 19, 2025.

The contract award is not designated with a set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/20/25, 2:28 PM